Glenmark gets tentative nod from USFDA for epilepsy drug
Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator for its generic version of Vimpat Oral Solution, used in treatment of epilepsy.
Mar 18, 2016, 12:05 PM IST
Jubilant Life zooms 10% as firm gets USFDA nod for drug
Jubilant Life Sciences shares soared almost 10 per cent, to touch its 52-week high level today, as the company received final approval from the US health regulator for its generic version of anti-depressant Paxil tablets.
Dec 01, 2015, 15:02 PM IST
Wockhardt hopeful of early resolution of USFDA row
The company has now increased its R&D spend and filed more ANDAs in the US and Britain for approvals.
May 29, 2015, 16:25 PM IST
